AEP's Texas Upside Hinges on Regulatory Execution

What happened

The Seeking Alpha article rates AEP Buy at ~$130, driven by a $100B investment plan targeting surging data center demand, especially in Texas and Ohio, and expects 10% annual EPS growth through 2031. Meanwhile, DeepValue's master report maintains a WAIT rating at $135.5, arguing the stock already prices in smooth monetization of 56 GW of signed large-load agreements and a $72B five-year capex plan. Key regulatory decisions, including the Texas UTM recovery (expected 1H26) and pending large-load tariffs, will determine whether heavy capex ($12.2B in 2026) converts into protected, finance-backed earnings or faces deferrals and disallowance. The balance sheet is stretched: net debt $49.97B, net debt/EBITDA 5.7, interest coverage 2.6, and free cash flow of -$246M at 2025-12-31, leaving limited room for execution setbacks. Texas expansion does offer upside, but only if favorable rulings preserve cost recovery and tariff protections, so waiting for these rulings may improve risk-adjusted entry.

Implication

For investors, the bullish article underscores AEP's data center growth potential, but the master report's analysis shows the stock is not cheap on a risk-adjusted basis. Near-term regulatory outcomes in Texas and other states will determine whether AEP can convert its pipeline into protected earnings without balance sheet strain. Given high leverage and negative free cash flow, any delay or disallowance could pressure the stock, while favorable rulings could unlock upside toward $155 bull case. The prudent approach is to monitor the 1H26 Texas UTM decision and final large-load tariffs; a positive resolution would support buying, while an adverse one would argue for trimming. Patience is warranted because the risk/reward is balanced at current levels.

Thesis delta

The new article suggests a larger $100B investment plan and stronger growth, but our core thesis remains WAIT: the market already prices in smooth execution, and regulatory risks are unresolved. This incremental information does not yet justify an upgrade, as the balance sheet constraints and dependency on favorable rulings remain key. We would upgrade to Buy if Texas approves full cost recovery and large-load tariffs retain protective terms, confirming the larger investment plan is financeable.